Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug combo trial offers hope for ovarian cancer patients

NCT ID NCT07024784

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called IMGN151, alone or with other cancer treatments, in about 377 adults with gynecologic cancers like ovarian cancer. The goal is to check safety and find the best dose. Participants get the drug through an IV and will have regular check-ups, blood tests, and scans over about 3 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fallopian tube cancer fallopian tube neoplasm female reproductive organ cancer neoplasm ovarian carcinoma ovarian serous adenocarcinoma primary peritoneal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FALLOPIAN TUBE CANCER GYNECOLOGIC CANCERS PLATINUM-SENSITIVE OVARIAN CANCER PRIMARY PERITONEAL CANCER (PSOC)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Holy Name Medical Center /ID# 279017

    RECRUITING

    Teaneck, New Jersey, 07666, United States

  • Hyogo Cancer Center /ID# 276940

    RECRUITING

    Akashi-shi, Hyōgo, 673-8558, Japan

  • National Cancer Center Hospital /ID# 276715

    RECRUITING

    Chuo-Ku, Tokyo, 104-0045, Japan

  • Next Virginia /ID# 279684

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • OU Health - Stephenson Cancer Center /ID# 277656

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

  • Providence Portland Medical Center /ID# 277727

    RECRUITING

    Portland, Oregon, 97213, United States

  • Rabin Medical Center /ID# 279142

    RECRUITING

    Petah Tikva, Central District, 4941492, Israel

  • Rambam Health Care Campus- Haifa /ID# 276004

    RECRUITING

    Haifa, 3109601, Israel

  • SCRI Oncology Partners /ID# 279733

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Shaare Zedek Medical Center /ID# 275854

    RECRUITING

    Jerusalem, 9103102, Israel

  • Tel Aviv Sourasky Medical Center /ID# 275852

    RECRUITING

    Tel Aviv, Tel Aviv, 6423906, Israel

  • Texas Oncology-Austin North /ID# 279958

    RECRUITING

    Austin, Texas, 78758, United States

  • The Cancer Institute Hospital Of JFCR /ID# 276711

    RECRUITING

    Koto-ku, Tokyo, 135-8550, Japan

  • The Chaim Sheba Medical Center /ID# 275997

    RECRUITING

    Ramat Gan, Tel Aviv, 5265601, Israel

  • University of Cincinnati Medical Center. /ID# 278925

    RECRUITING

    Cincinnati, Ohio, 45219, United States

  • Women & Infants Hospital /ID# 277930

    RECRUITING

    Providence, Rhode Island, 02905, United States